NCT06966674Recruiting
No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
Assessment of No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
Source: ClinicalTrials.gov · Last updated 13 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 4 May 2025
- Start date
- 12 May 2025
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- Kafrelsheikh University
- Diseases
- Coronary artery disease
- NCT number
- NCT06966674
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 12 May 2025 to the primary completion date, 1 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with thrombolytic drugs in the previous 24 hours.
Other illness
- Known malignancy.
- End-stage liver disease.
- Renal failure with glomerular filtration\<30 ml/min.
Other
- Thrombocytopenia.
- Cardiogenic shock.
- Contraindication for the use of tirofiban.
Who the study is looking for
- Age ≥ 18 years old.
- Both sexes.
- Patients with STEMI. ST-segment elevated myocardial infarction is defined as typical chest pain \>30 minutes with ST-segment elevation of \>1 mm in at least 2 consecutive leads on the electrocardiogram or new-onset left bundle brunch block.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kafrelsheikh University Coordinator of this site? Confirm its status | Kafr ash Shaykh | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.